0001213900-24-033831.txt : 20240417
0001213900-24-033831.hdr.sgml : 20240417
20240417163233
ACCESSION NUMBER: 0001213900-24-033831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240415
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jermasek Douglas
CENTRAL INDEX KEY: 0001955273
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 24851542
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL
STREET 2: SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
ownership.xml
X0508
4
2024-04-15
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001955273
Jermasek Douglas
C/O UNICYCIVE THERAPEUTICS
4300 EL CAMINO REAL SUITE 210
LOS ALTOS
CA
94022
0
1
0
0
EVP of Corporate Strategy
0
Stock Options
1.14
2024-04-15
4
A
0
463250
0
A
2034-04-15
Common Stock
463250
1973250
D
115,813 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.
/s/ Doug Jermasek
2024-04-17